AI CT Tool for Early Pulmonary Fibrosis Detection Enters Phase 3, With Eric White

HCPLive spoke with Eric White, MD, MS, FCCP, ATSF to discuss the DROP-FPF trial and the pivotal role that Brainomix e-Lung HRCT biomarkers will play in this pioneering Phase 3 study in pulmonary fibrosis. The conversation explored how automated CT-based AI imaging is positioned to support earlier detection and trial endpoints in ILD.